The United States represents one of the largest contributors to the anemia drugs industry due to the high prevalence of iron deficiency anemia, chronic kidney disease-associated anemia, cancer-related anemia, and inherited blood disorders. Increasing healthcare expenditure, widespread access to advanced diagnostic technologies, and strong adoption of innovative therapies such as...